Aspirin cuts cancer rates in people with hereditary risk by more than half
Research has finally provided proof that a regular dose of aspirin reduces the long-term risk of cancer in people with a family history of the disease by around 60 per cent.
Health News
Leeds £1.5 million Investigator Award for hepatitis C virus research
Professor Mark Harris, from the Institute of Molecular and Cellular Biology, has been appointed as a Wellcome Trust Senior Investigator, with £1.5 million funding to pursue his research goals.
Protecting the brain when energy runs low
Researchers from the Universities of Leeds, Edinburgh and Dundee have shed new light on the way that the brain protects itself from harm when 'running on empty'.
Muslim leaders get help to teach smoke-free message
A new resource to help Muslim religious teachers educate their communities about the health risks of second hand smoke and the importance of having a smoke-free home is being launched in Leeds.
Three gene faults linked to melanoma
An international team of researchers has discovered the first DNA faults linked to melanoma - the deadliest skin cancer - that are not related to hair, skin or eye colour.
Children's intensive care comes under scrutiny
Standards of care in children's intensive care units come under scrutiny in a new audit report published today by the University of Leeds and the University of Leicester.
Ceremony marks student doctors' professionalism
The professionalism of student doctors has been recognised in a special ceremony at the University of Leeds' School of Medicine - the first of its kind in the UK.
Pale people may need vitamin D supplements
Fair-skinned people who burn quickly in the sun may need to take supplements to ensure they get the right amount of vitamin D, according to a new study.
Researchers call for more awareness of male breast cancer as cases rise
Awareness of male breast cancer is low and most men do not even know they are at risk despite an increase in cases, reveals new research from the University of Leeds.
Bone drug is mixed blessing for breast cancer patients
A drug used to protect bone may extend survival in older breast cancer patients, according to researchers at the Universities of Sheffield and Leeds.